Nkarta (NKTX) traded up 2.23 % during a 24 hours period ending at 03:38 AM Central Europe on Wednesday 28th. One Nkarta stock can currently be bought for about USD 1.7 on popular exchanges. Current supply of Nkarta stocks is 71.6 mn. Nkarta has a current market capitalization of USD 128.2 mn and approximately USD 2.1 mn worth of Nkarta was traded on exchanges in the last 24 hours. Since last month end, Nkarta has traded -31.46 % down. Simple moving average of last 200 days is at USD 2.54. The highest price of past 52 weeks was recorded at USD 3.72 on 07/09/2026. 52 weeks low was at USD 1.66 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Indigo Acquisition (INAC) traded flat 0 % and now trades at USD 10.4. Indigo Acquisition has a market capitalisation of USD 153.8 mn.
Sutro Biopharma (STRO) traded down -4.72 % and now trades at USD 8.87. Sutro Biopharma has a market capitalisation of USD 150.6 mn.
Aa Mission Acquisition (YCY) traded down -0.1 % and now trades at USD 10.31. Aa Mission Acquisition has a market capitalisation of USD 151.8 mn.
Espey Mfg & Electronics (ESP) traded up 1.96 % and now trades at USD 54.57. Espey Mfg & Electronics has a market capitalisation of USD 151.6 mn. Espey Mfg & Electronics has a current price to earnings ratio of 13.25.
Duluth (DLTH) traded up 1.9 % and now trades at USD 4.07. Current market capitalisation for Duluth is USD 150.1 mn. Duluth has a current price to earnings ratio of 23.23.
About Nkarta
Nkarta Inc. is a biotech company that operates in the health care sector, with its base located in South San Francisco, United States. The company specializes in developing and discovering therapies for immune systems and cancer indications, serving patients in the state of California. You can find more information about their activities on their website at www.nkartatx.com and they are listed on the Nasdaq stock exchange.